Strides Pharma Q4 results: Net loss of Rs 206.57 crore

Strides Pharma Q4 results: Net loss of Rs 206.57 crore

Strides Pharma Q4 results: Net loss of Rs 206.57 crore

Strides Pharma Q4 results:

The consolidated net loss of Rs 206.57 crore reported by Strides Pharma Science on May 20th for the quarter ended March 31 largely due to the one-time exceptional item. 

Strides Pharma Science has announced in a filing to the BSE that the company had a net income of Rs 44.70 crore for the period of the previous fiscal year. 

The total revenue of the company for this quarter amounted to Rs 618.64 crore. For the same time last year, it was Rs 616.18 crore, it said. 

The company reported a net loss of Rs 170 crore, mainly on account of the withdrawal of ranitidine from the US market, in terms of results for the year. 

The firm reported a net income of Rs 30.58 crore for the financial year ending March of this year. For the last fiscal year, the listing stated, it was Rs 329.87 crore. The company’s operations sales Rs 2,751.97 crore for the financial year ending in March 2020. For the fiscal year, it added Rs 2,178.37 crore.

“Following the unexpected USFA guidance for withdrawal of ranitidine on the last day of the FY20, the 2020 financial year has made both the strategic and financial targets for Strides,” said Strides Pharma Science CEO and MD R Ananthanarayanan.

According to Strides, its businesses are optimistic that it can maintain traction and significantly expand, contributing to a healthy financial result in 2020-21. 

A final dividend of Rs 2 per share provided by the Board of Directors of the company, the report states.

Besides, on May 21st, the share of Strides Pharma Science Ltd traded with the bullish trend. It traded with a gain of 5.05 points reached 426.20 INR with 1.20% up in NSE. Whereas in BSE, it traded with a gain of 5.90 points reached 426.95 INR with 1.40% up.

May 21st Stock Market Sensex and Nifty

May 21st Stock Market: On the fourth day of the week, the stock market trading with the bullish trend. The Sensex trades with a gain of 313.95 points reached a 31,132.56 level with 1.02% up. Whereas, Nifty traded with a gain of 101.85 points reached 9,168.40 level with 1.12% up.

In the border market, the S&P BSE Midcap traded with a gain of 154.00 points reached 11,432.22 level with 1.37% up. Whereas, S&P BSE SmallCap traded with a gain of 155.96 points reached 10,628.33 level with 1.38% up. At the same time, Nifty bank traded with a gain of 282.05 points reached 18,122.25 with 1.58% up.

Top Gaining Stocks: Hero Motocorp, Hindalco Industries, Bharti Infratel, ITC, and Maruti Suzuki India Ltd.

Top Losing Stocks: Shree Cement, NTPC, Grasim Industries, Dr.Reddy’s Laboratories, and Larsen & Toubro Ltd.

Related posts

Motherson Sumi up 14% after board approves fund raise of Rs 1,000 cr

Tarun

January 20th Stock Market Sensex and Nifty

Stock Investor

NIIT Technologies Q4 results: consolidated net profit of Rs 113.6 crores

Tarun